Log In
Print this Print this

Fado, fadolmidine

  Manage Alerts
Collapse Summary General Information
Company Recro Pharma Inc.
DescriptionAgonist of all subtypes of alpha-2 adrenoreceptors.
Molecular Target Adrenergic receptor alpha 2 (ADRA2)
Mechanism of ActionAdrenergic receptor alpha 2 (ADRA2) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat neuropathic pain; Treat post-operative pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today